TARGET-DERM Study for Atopic Dermatitis
Protocol: STUDY00003546
Full Title
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
Description
This study enrolls children and adults with skin conditions such as Atopic Dermatitis (eczema). The purpose of this study is to learn more about people who have been diagnosed with these conditions, including information about their health and the medications they take to manage their disease. Specifically, we want to understand how different treatments may affect the health of some patients differently than others.

By participating in the study, you will allow your medical records to be confidentially shared with our team. There are also optional parts of the study that you may choose to participate in or not, such as health questionnaires and biospecimen collections (blood, saliva, and skin cells). You may also choose to be contacted in the future to complete health surveys.

Technical Description

This is a 5-year, longitudinal, observational study of adult and pediatric participants being treated for Immune-Mediated Inflammatory Skin Conditions such as Atopic Dermatitis.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
Adults or children.
Being prescribed medical therapy for atopic dermatitis.
Age Group: Both Adults and Children
Principal Investigator: HEATHER LEHMAN
ClinicalTrials.gov: Open Study
Contact(s)
HEATHER LEHMAN
hkm@buffalo.edu
+1 716-878-7105
Want to Learn More?
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.